ClinicalTrials.gg
Drug

Loperamide clinical trials

Also written Imodium.

studies test it
31
open now
2
in phase 3
7
first study started
1997

How each study uses Loperamide is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Loperamide studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
28 Dec 1976 · IMODIUM · NDA 017690 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Loperamide
20
Loperamide Hydrochloride
2
Loperamide HCl
2

Brand

Imodium
8

Studies by the year they started

31 studies that test it; most in 2014 (5)

Studies that test Loperamide, by start year
YearStudies
19971
20023
20042
20071
20083
20091
20131
20145
20152
20161
20171
20181
20191
20203
20211
20223
20231

By phase

A phase 1/2 study counts in both.

Early Phase 1
1
Phase 1
10
Phase 2
7
Phase 3
7
Phase 4
7
No phase
3

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 10 · Other 21

Jiangsu HengRui Medicine Co., Ltd. (2) · The University of Texas Health Science Center, Houston (2) · Johnson & Johnson Consumer and Personal Products Worldwide (2) · University of Pennsylvania (1) · Spanish Breast Cancer Research Group (1) · Janssen Research & Development, LLC (1) · Rush University Medical Center (1) · Centre de recherche du Centre hospitalier universitaire de Sherbrooke (1)

Often tested with

Tested in the same studies.

Neratinib (2) · Simethicone (2) · Bentonite (2) · Butylscopolammonium Bromide (1) · Octreotide (1) · Pyrotinib (1) · Shr-1258 dimaleate (1) · Senna Extract (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 2

Studies that test Loperamide.

Studies

Open first, then newest update. How each study uses Loperamide is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 31

See all 31 studies that test Loperamide →

Given beside what is tested · 18 — Loperamide is usual care or a partner of the new treatment
As the comparator · 3 — what is tested is compared with Loperamide

Codes

What other systems call Loperamide · ClinicalTrials.gg INT007747

  • MeSH (NLM) D008139LoperamideConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 6X9OC3H4IILOPERAMIDEConfirmed FDA, NLM, Wikidata
  • RxNorm 6468Confirmed FDA, Wikidata
  • Wikidata Q423751loperamideConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C618LoperamideOne source FDA
  • DrugBank DB00836One source Wikidata

Also registered as loperamide hydrochloride (UNII 77TI35393C · RxNorm 82038).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.